YOD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.036200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.207800E-01
Normal-vs-Stage2
4.570200E-01
Normal-vs-Stage3
8.884600E-01
Normal-vs-Stage4
2.951200E-01
Stage1-vs-Stage2
6.133200E-01
Stage1-vs-Stage3
3.919400E-01
Stage1-vs-Stage4
3.715000E-01
Stage2-vs-Stage3
3.286000E-01
Stage2-vs-Stage4
7.956800E-01
Stage3-vs-Stage4
2.083200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.450800E-01
Normal-vs-AfricanAmerican
1.746210E-01
Normal-vs-Asian
2.980200E-01
Caucasian-vs-AfricanAmerican
6.997200E-01
Caucasian-vs-Asian
3.109000E-01
AfricanAmerican-vs-Asian
7.222400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.213600E-01
Normal-vs-Female
4.644800E-01
Male-vs-Female
5.979600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.806400E-01
Normal-vs-Age(41-60Yrs)
3.570200E-01
Normal-vs-Age(61-80Yrs)
5.471800E-01
Normal-vs-Age(81-100Yrs)
7.784200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.456000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.355000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.552800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.799800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.737840E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.979240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.189400E-01
Normal-vs-Daily Drinker
6.402200E-01
Normal-vs-Weekly Drinker
4.958600E-01
Normal-vs-Occasional Drinker
2.373400E-01
Normal-vs-Social Drinker
4.921600E-01
Non Drinker-vs-Daily Drinker
5.251600E-01
Non Drinker-vs-Weekly Drinker
8.427400E-01
Non Drinker-vs-Occasional Drinker
5.767200E-01
Non Drinker-vs-Social Drinker
7.115000E-01
Daily Drinker-vs-Weekly Drinker
3.905000E-01
Daily Drinker-vs-Occasional Drinker
1.383960E-01
Daily Drinker-vs-Social Drinker
7.495000E-01
Weekly Drinker-vs-Occasional Drinker
7.920800E-01
Weekly Drinker-vs-Social Drinker
5.827800E-01
Occasional Drinker-vs-Social Drinker
2.680000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.554000E-02
Normal-vs-Grade 2
8.076000E-02
Normal-vs-Grade 3
4.332500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.781700E-03
Grade 1-vs-Grade 3
2.696300E-02
Grade 1-vs-Grade 4
6.554000E-02
Grade 2-vs-Grade 3
8.286200E-01
Grade 2-vs-Grade 4
8.076000E-02
Grade 3-vs-Grade 4
4.332500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.161400E-01
Normal-vs-NonDiabetic
4.348000E-01
Diabetic-vs-NonDiabetic
6.727700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.826200E-01
Normal-vs-NoPancreatitis
5.302000E-01
Pancreatitis-vs-NoPancreatitis
8.989800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.806000E-01
Normal-vs-N1
4.932000E-01
N0-vs-N1
4.461600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.189400E-01
Normal-vs-TP53-NonMutant
4.279000E-01
TP53-Mutant-vs-TP53-NonMutant
6.730100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
